(Q37483049)

20 August 2017

1 reference

title

A role for single-pill triple therapy in hypertension (English)

1 reference

20 August 2017

main subject

arterial hypertension

0 references

author name string

Fernando Elijovich

series ordinal

1

1 reference

20 August 2017

Cheryl Laffer

series ordinal

2

1 reference

20 August 2017

publication date

14 May 2009

1 reference

Therapeutic advances in cardiovascular disease

20 August 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

20 August 2017

volume

3

1 reference

20 August 2017

issue

3

1 reference

20 August 2017

page(s)

231-240

1 reference

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

Patients with resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

Achieving and maintaining National Cholesterol Education Program low-density lipoprotein cholesterol goals with five statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

Novel use of Kaplan-Meier methods to explain age and gender differences in hypertension control rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

Achieving blood pressure goals globally: five core actions for health-care professionals. A worldwide call to action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

Achieving goal blood pressure in patients with type 2 diabetes: conventional versus fixed-dose combination approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

Treatment of hypertension in patients 80 years of age or older

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

Combination pharmacotherapy for cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

Efficacy and safety of amlodipine/valsartan compared with amlodipine monotherapy in patients with stage 2 hypertension: a randomized, double-blind, multicenter study: the EX-EFFeCTS Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

What factors contribute to the inadequate control of elevated blood pressure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

Characterization of resistant hypertension: association between resistant hypertension, aldosterone, and persistent intravascular volume expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

An oxidized derivative of linoleic acid affects aldosterone secretion by adrenal cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

Evolving strategies for the use of combination therapy in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

Prevalence, awareness, treatment, and control of hypertension in china

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

Results of treatment in malignant hypertension: a seven-year experience in 94 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

Prompt, aggressive BP lowering in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

The T8590C polymorphism of CYP4A11 and 20-hydroxyeicosatetraenoic acid in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

Differential regulation of natriuresis by 20-hydroxyeicosatetraenoic Acid in human salt-sensitive versus salt-resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

Combining renin-angiotensin-aldosterone system blockade with diuretic therapy for treatment of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

Effects of a structured treatment algorithm on blood pressure goal rates in both stage 1 and stage 2 hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

Observational studies of antihypertensive medication use and compliance: is drug choice a factor in treatment adherence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

Rationale for fixed-dose combinations in the treatment of hypertension: the cycle repeats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

Adherence to antihypertensive therapy with fixed-dose amlodipine besylate/benazepril HCl versus comparable component-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

A strategy to reduce cardiovascular disease by more than 80%

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

Differing mechanisms of action of angiotensin-converting enzyme inhibition in black and white hypertensive patients. The Trandolapril Multicenter Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709334947

21 January 2018

Identifiers

DOI

10.1177/1753944709334947

1 reference

20 August 2017

1 reference